UNITY Biotechnology Reports Granting of New Employment Inducement Award
UNITY Biotechnology Reports Granting of New Employment Inducement Award
SOUTH SAN FRANCISCO, Calif., Jan. 07, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. ("UNITY") [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today announced that on January 6, 2025, the Compensation Committee of the Board of Directors (the "Board") granted a stock-based award to a new employee, Federico Grossi, UNITY's Chief Medical Officer, covering options to purchase 150,000 shares of UNITY common stock. The stock-based award was granted pursuant to the UNITY 2020 Employment Inducement Incentive Plan, as amended, which was approved by the Board in March 2020 to provide for grants to newly hired employees as a material inducement for them to commence employment with UNITY in accordance with Nasdaq Stock Market Rule 5635(c)(4).
加利福尼亞州南舊金山，2025年1月7日（全球新聞網絡）—— Unity Biotechnology, Inc.（"UNITY"）[納斯達克：UBX]是一家開發治療藥物以減緩、停止或逆轉衰老疾病的生物技術公司，今天宣佈在2025年1月6日，董事會的薪酬委員會（"董事會"）向新員工Federico Grossi授予了一項基於股票的獎勵，涵蓋購買150,000股UNITY普通股的期權。該股票獎勵是根據已修訂的UNITY 2020年就業誘導激勵計劃授予的，該計劃於2020年3月獲得董事會批准，以便爲新聘員工提供獎勵，以作爲他們開始在UNITY工作的實質性誘因，符合納斯達克證券市場規則5635(c)(4)。
About UNITY
UNITY is developing a new class of therapeutics to slow, halt or reverse diseases of aging. UNITY's current focus is on creating medicines to selectively eliminate or modulate senescent cells and thereby provide transformative benefit in age-related ophthalmologic and neurologic diseases. More information is available at or follow us on Twitter and LinkedIn.
關於UNITY
UNITY正在開發一種新類型的治療藥物，以減緩、停止或逆轉衰老疾病。UNITY目前的重點是創造藥物，以選擇性地消除或調節衰老細胞，從而在與年齡相關的眼科和神經科疾病中提供變革性的好處。有關更多信息，請訪問我們的網站或在Twitter和LinkedIn上關注我們。
Media Contact
Inizio Evoke Comms
Katherine Smith
katherine.smith@inizioevoke.com
媒體聯繫
啓始Evok通訊
凱瑟琳·史密斯
katherine.smith@inizioevoke.com
Investor Contact
LifeSci Advisors, LLC
Joyce Allaire
jallaire@lifesciadvisors.com
投資者聯繫
生命科學顧問公司
喬伊斯·阿拉爾
jallaire@lifesciadvisors.com
Source: Unity Biotechnology, Inc.
來源：Unity Biotechnology, Inc.
譯文內容由第三人軟體翻譯。
